Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralipid infusion before embryo transfer in women with two prior unsuccessful embryo transfers
IRCT20140305016858N5Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- May 2021
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Intralipid 10% in Recurrent Implantation Failure (RIF) and female infertility (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Positive pregnancy test and Fetal heart at week 6. Started May 2021; status: completed.
02
Drugs
Intralipid 10%
03
Conditions
Recurrent Implantation Failure (RIF)female infertility
Beyond the preview
Go deeper on IRCT20140305016858N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140305016858N5.